Jazz Pharmaceuticals Officer Renee D. Gala Files Form 144 to Sell $486K in Common Stock
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale • Company: Jazz Pharmaceuticals plc (NASDAQ: JAZZ) • Insider: Renee D. Gala (Officer) • Shares to Sell: 2,000 Common Shares • Estimated Value: $486,060.00 (~$243.03/share) • Broker: Morgan Stanley Smith Barney LLC • Plan Date: Rule 10b5-1 plan adopted June 4, 2026
Comprehensive Analysis
Executive Summary
On September 8, 2026, Renee D. Gala, an Officer at Jazz Pharmaceuticals plc ($JAZZ), submitted a Form 144 filing notifying the SEC of a proposed sale of 2,000 shares of common stock through Morgan Stanley Smith Barney LLC. The aggregate market value of the proposed transaction is $486,060.00, representing an implied share price of approximately $243.03.
Transaction & Acquisition Details
- Security: Common Stock
- Shares Proposed for Sale: 2,000
- Aggregate Market Value: $486,060.00
- Acquisition Origin: The shares were acquired directly from the issuer on June 30, 2026, pursuant to a Restricted Stock vesting.
- Trading Plan: The proposed sale is executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 4, 2026.
Market Impact & Significance
- Trading Significance: Low. The proposed sale represents a modest dollar value relative to the company's total outstanding shares (64,914,577) and is executed under a pre-established Rule 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.